Anavex Life Sciences Corp. (AVXL)
$1.65-9.34%Close
SELLCRISIS · day 26
Key stats
Short interest · FINRA settlement 2026-09-15
- Market cap
- $153M
- Beta
- 1.14
- P/E (TTM)
- -6.29
- Short % float
- 15.96%
- Days to cover
- 25.1
- SI change
- +3.1%
- 1W
- -29.79%
- 1M
- -42.11%
- vs SPY 1W
- -30.99%
- vs SPY 1M
- -42.57%
Industry peers
FMP comparable companies · ranked by market cap
- ERASSELLErasca, Inc.$4.9BRECOVERYQ 3$14.21-0.14%
- MBXSELLMBX Biosciences, Inc. Common Stock$2.7BRECOVERYQ 41$57.75+0.05%
- ABSIBUYAbsci Corporation$1.7BRECOVERYQ 4$10.14+4.16%
- MGTXSELLMeiraGTx Holdings plc$1.0BCRISISQ 7$11.13+1.20%
- MLTXSELLMoonLake Immunotherapeutics$963MCRISISQ 1$11.45-0.26%
- ATXSAstria Therapeutics, Inc.$718M$12.58
- CTMXSELLCytomX Therapeutics, Inc.$599MCRISISQ 7$2.75+0.78%
- VALNSELLValneva SE$582MCRISISQ -0$6.14+1.39%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 7
- VALUE
- 6
- GROWTH
- 39
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-12.7%
REV YoY-
ROE-21.1%
EPS YoY-
ROA-20.0%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-6.29
P/E FWD-
SECTOR PE20.58
INDUSTRY PE13.91
P/B1.34
P/FCF-
EV/EBITDA-1.56
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO15.62
ND/EBITDA-
BETA1.14
Company news
Loading headlines…